Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;46(3):825-39.
doi: 10.1007/s10803-015-2619-y.

Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies

Natascia Brondino  1 , Laura Fusar-Poli  2 , Cristina Panisi  2 , Stefano Damiani  2 , Francesco Barale  2 , Pierluigi Politi  2
Affiliations

Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies

Natascia Brondino et al. J Autism Dev Disord. 2016 Mar.

Abstract

Autism spectrum disorders are an emerging health problem worldwide, but little is known about their pathogenesis. It has been hypothesized that autism may result from an imbalance between excitatory glutamatergic and inhibitory GABAergic pathways. Commonly used medications such as valproate, acamprosate, and arbaclofen may act on the GABAergic system and be a potential treatment for people with ASD. The present systematic review aimed at evaluating the state-of-the-art of clinical trials of GABA modulators in autism. To date there is insufficient evidence to suggest the use of these drugs in autistic subjects, even if data are promising. Of note, short-term use of all the reviewed medications appears to be safe. Future well designed trials are needed to elucidate these preliminary findings.

Keywords: Autism spectrum disorder; Clinical trials; GABA; Systematic review.

PubMed Disclaimer

References

    1. J Autism Dev Disord. 2014 Apr;44(4):981-7 - PubMed
    1. Acta Paediatr. 2010 Dec;99(12):1885-8 - PubMed
    1. Autism. 2015 Feb;19(2):149-57 - PubMed
    1. Exp Neurol. 2013 Sep;247:496-505 - PubMed
    1. Neuropharmacology. 2002 Feb;42(2):199-209 - PubMed

Publication types

MeSH terms